Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Siefker-Radtke

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Current Oncology Reports|May 7, 2010
Bladder cancer: can we move beyond chemotherapy?Arlene Siefker-Radtke
Seminars in Oncology|October 9, 2012
Urachal adenocarcinoma: a clinician's guide for treatmentArlene Siefker-Radtke
Expert Review of Anticancer Therapy|June 10, 2006
Systemic chemotherapy options for metastatic bladder cancerArlene Siefker-Radtke
The Journal of Urology|March 13, 2016
Editorial CommentArlene Siefker-Radtke
Expert Review of Anticancer Therapy|December 22, 2006
Urachal carcinoma: surgical and chemotherapeutic optionsArlene Siefker-Radtke
Nature Reviews. Urology|December 6, 2017
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibitionArlene Siefker-Radtke, Brendan Curti
European Urology|October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urotheliumChristopher J Logothetis, Arlene Siefker-Radtke
Urologic Oncology|December 25, 2003
Neoadjuvant chemotherapy for bladder cancerRandall Millikan, Arlene Siefker-Radtke, H Barton Grossman
European Urology|September 14, 2020
Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial CarcinomaAlexander Andreev-Drakhlin, Jianjun Gao, Arlene Siefker-Radtke
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapyRobert S Svatek, Arlene Siefker-Radtke, Colin P Dinney
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Current Oncology Reports|May 7, 2010
Bladder cancer: can we move beyond chemotherapy?Arlene Siefker-Radtke
Seminars in Oncology|October 9, 2012
Urachal adenocarcinoma: a clinician's guide for treatmentArlene Siefker-Radtke
Expert Review of Anticancer Therapy|June 10, 2006
Systemic chemotherapy options for metastatic bladder cancerArlene Siefker-Radtke
The Journal of Urology|March 13, 2016
Editorial CommentArlene Siefker-Radtke
Expert Review of Anticancer Therapy|December 22, 2006
Urachal carcinoma: surgical and chemotherapeutic optionsArlene Siefker-Radtke
Nature Reviews. Urology|December 6, 2017
Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibitionArlene Siefker-Radtke, Brendan Curti
European Urology|October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urotheliumChristopher J Logothetis, Arlene Siefker-Radtke
Urologic Oncology|December 25, 2003
Neoadjuvant chemotherapy for bladder cancerRandall Millikan, Arlene Siefker-Radtke, H Barton Grossman
European Urology|September 14, 2020
Levelling the Evidence: A Comparison of Neoadjuvant and Adjuvant Treatment for Upper Tract Urothelial CarcinomaAlexander Andreev-Drakhlin, Jianjun Gao, Arlene Siefker-Radtke
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapyRobert S Svatek, Arlene Siefker-Radtke, Colin P Dinney
Pageof 8